DSE:PHARMAID

Pharma Aids Limited announcements

270 Dhaka Stock Exchange announcements for Pharma Aids Limited (PHARMAID) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2007 (5).

  1. Trading of the shares of the company will also be allowed in spot market with cum benefit from 11.12.07 to 12.12.07, as

    Trading of the shares of the company will also be allowed in spot market with cum benefit from 11.12.07 to 12.12.07, as book closure will start from 17.12.07.

  2. As per audited accounts as on 30.06.07, the Company has reported net profit of Tk. 10.33 m with EPS of Tk. 198.61 as aga

    As per audited accounts as on 30.06.07, the Company has reported net profit of Tk. 10.33 m with EPS of Tk. 198.61 as against Tk 6.85 m and Tk. 131.74 respectively as on 30.06.06.

  3. In response to a DSE query, the company has informed that "we do not have any undisclosed material decision/information

    In response to a DSE query, the company has informed that "we do not have any undisclosed material decision/information in relation to our Company that might have an impact on the trade of the shares of our Company. However, our production and sales have been increasing in every year since 2004-05 financial year. Besides, we have opened a Letter of Credit in the last month for another production line for expansion of our capacity".

  4. The company will be placed in "A" category from existing "B" category with effect from 28.02.07 as the company reported

    The company will be placed in "A" category from existing "B" category with effect from 28.02.07 as the company reported payment of cash dividend @ 25%.

  5. As per un-audited half yearly accounts as on 31.12.06, the Company has reported net profit of Tk. 3.19 m with EPS of Tk.

    As per un-audited half yearly accounts as on 31.12.06, the Company has reported net profit of Tk. 3.19 m with EPS of Tk. 61.38.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.